Ayotte Vetoes New Hampshire Medical Cannabis Home Cultivation Bill

Governor Cites Enforcement Concerns in Veto Message

Ayotte's veto message focused on the difficulty of monitoring home cultivation and potential diversion to the illicit market. The governor argued that New Hampshire's existing therapeutic cannabis program, which operates through four licensed Alternative Treatment Centers (ATCs), provides adequate patient access without the enforcement challenges posed by decentralized home growing. She didn't specify which statute or regulatory framework HB 1633 would undermine.

HB 1633 Would Have Authorized Six-Plant Home Grows

The vetoed bill would have amended RSA 126-X, New Hampshire's Therapeutic Use of Cannabis statute, to permit qualified patients and designated caregivers to cultivate up to six mature plants. Patients living more than 30 miles from an ATC would've been prioritized for home cultivation permits during an initial two-year phase-in period. The bill included provisions for secure indoor growing areas and plant tagging requirements intended to prevent diversion.

Sponsors said the measure addressed access gaps in rural counties where the nearest ATC can be over an hour's drive. New Hampshire currently operates four ATCs statewide. They serve approximately 8,200 registered patients as of May 2026.

Bipartisan Legislative Support Could Not Overcome Veto

HB 1633 passed the New Hampshire House 218-156 in March 2026 and cleared the Senate 14-10 in May. The margins fall short of the two-thirds supermajority required to override a gubernatorial veto in New Hampshire. House leadership hasn't yet announced whether an override attempt will be scheduled, though the vote counts suggest such an effort would likely fail.

Patient advocacy groups including the New Hampshire chapter of Americans for Safe Access backed the bill. They testified that home cultivation would reduce costs for patients facing monthly ATC expenses averaging $300-$400.

New Hampshire Remains One of Few Medical-Only States Banning Home Grows

With this veto, New Hampshire joins a shrinking group of medical cannabis states that prohibit any form of home cultivation. Of the 38 states with medical cannabis programs, only seven—including New Hampshire, Delaware, and Pennsylvania—maintain complete bans on patient cultivation. Most medical states allow between six and twelve plants per patient, with some imposing distance-based eligibility similar to HB 1633's proposed framework.

For full background on this story, see the CannIntel topic hub on New Hampshire Medical Cannabis Program.

ATC Operators Opposed the Bill, Citing Market Disruption

New Hampshire's four licensed ATCs—Prime ATC, Sanctuary ATC, Temescal Wellness, and Granite State Dispensary—submitted joint testimony opposing HB 1633. The operators said home cultivation would undercut their ability to maintain lab testing, quality control, and seed-to-sale tracking standards mandated under state rules. They also warned that reduced patient volume could threaten the financial viability of rural ATC locations.

ATC revenue in New Hampshire totaled approximately $28 million in 2025, according to Department of Health and Human Services data. Industry analysts estimate that home cultivation, if permitted, could reduce ATC sales by 15-20% within two years as cost-conscious patients shift to self-supply.

Veto Comes as Adult-Use Legalization Debate Continues

Ayotte's veto arrives amid ongoing legislative debate over adult-use cannabis legalization in New Hampshire. A separate bill, HB 1598, which would establish a regulated adult-use market with state-run retail stores, remains in committee and faces uncertain prospects. Ayotte hasn't stated a clear position on HB 1598 but has previously expressed skepticism about recreational legalization without stronger impaired-driving enforcement tools.

New Hampshire is now the only New England state without either adult-use legalization or decriminalization of home cultivation. Vermont, Maine, Massachusetts, Connecticut, and Rhode Island all permit home growing under their adult-use frameworks.

What Happens Next for Home Cultivation Advocates

Patient advocates are expected to reintroduce home cultivation language in the 2027 legislative session, potentially with tighter plant limits or enhanced compliance provisions. Some lawmakers have floated compromise frameworks that would cap initial home grows at three plants or require annual inspections by local health officers. Whether such modifications could secure gubernatorial support remains unclear.

The next legislative session convenes in January 2027. Until then, New Hampshire patients remain dependent on the four-ATC distribution system for legal access to medical cannabis.